+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 50Years - 75Years
All Genders
ID05155137

Phase 3 Study of Polypill and Stroke Riskometer to Prevent Stroke and Cognitive Decline in Adults Aged 50 to 75

Led by Hospital Moinhos de Vento · Updated on 2025-01-23

8518

Participants Needed

2

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether a combination pill called the polypill, alone or combined with lifestyle changes using the Stroke Riskometer app, can reduce strokes and cognitive decline in adults aged 50 to 75 years with low to moderate stroke risk. This phase III, randomized, placebo-controlled clinical trial involves 8,518 participants in Brazil over 3 years to address the high stroke burden despite current prevention methods. The study compares the polypill containing valsartan, amlodipine, and rosuvastatin with a placebo and lifestyle modification against usual care. Participants first complete a 30-day run-in phase on the active polypill before being randomly assigned to one of four groups polypill with the Stroke Riskometer, placebo with the Stroke Riskometer, polypill without the Stroke Riskometer, or placebo without it. Dosage adjustments of amlodipine are allowed for adverse events. The trial is conducted across 80 health units affiliated with 20 research centers and includes a smaller part assessing surrogate endpoints like blood pressure reduction and stroke risk scale changes over 9 months. Throughout the 3-year study, participants undergo regular assessments of stroke incidence, cognitive decline, blood pressure, cholesterol, cardiovascular risk factors, and quality of life. Researchers will also monitor adverse events and the cost of stroke treatment. Participants will be followed closely for safety and adherence, with the primary outcomes being stroke and cognitive decline rates at the end of the study period.

CONDITIONS

Brief Title

Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)

Research Team

S

Sheila CO Martins, PhD

T

Thais L Secchi, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here